What business loan options are available for medical spas?

Medical spas sit at the intersection of healthcare and personal care services — operating under NAICS 812199 (Other Personal Care Services) while subject to medical licensing, FDA device regulations, and state corporate-practice-of-medicine (CPOM) rules that most personal care businesses never face. Capital requirements are high: a single medical-grade laser or body-contouring platform can run $80,000–$250,000+, and a full build-out with multiple devices, treatment rooms, and a licensed medical director can require $300,000–$800,000 before revenue reaches a sustainable run rate. Injectables inventory (Botox, dermal fillers) must be purchased and stored in advance of appointments, creating a recurring working-capital cycle. Lenders that understand this structure — device-heavy fixed costs, membership revenue offsets, injectables inventory cash flow, and the physician/NP/PA oversight requirement — can underwrite med spas effectively.

How med spa cash flow, device-capital intensity, and medical-director regulation affect loan qualification

Med spa revenue mixes cash-pay aesthetic services (Botox, filler, laser hair removal, body contouring), package prepayments, and membership subscriptions — with virtually no insurance reimbursement. The cash-pay model produces strong same-day deposit consistency that lenders score favorably; the membership component generates predictable recurring revenue that supports DSCR calculations. The structural challenge is the device capital stack: a practice may carry $500,000+ in equipment debt against revenue that took 12–18 months to ramp to break-even. Lenders underwrite med spas on normalized EBITDA plus device depreciation, not raw net income. The medical director is non-negotiable: most states require a licensed physician to supervise injectable and laser procedures; a practice without an active, documented medical director agreement is not operationally compliant and will not close an SBA or conventional loan. FTC health claims guidelines also govern before/after marketing — practices with non-compliant advertising create regulatory risk that lenders note.

Loan types available to medical spa operators

• SBA 7(a) — up to $5M; preferred for new location build-outs, practice acquisitions with goodwill (client list + device fleet), partner buyouts, and working capital; 10-year terms on equipment and working capital, 25-year terms with real estate
• SBA 504 — up to $5.5M total project; for purchasing owner-occupied med spa real estate; fixed 20-year CDC rate; requires 51% owner-occupancy
• Equipment financing — lasers, IPL devices, body-contouring platforms, RF microneedling, CoolSculpting/EMSCULPT units, photobiomodulation beds; equipment serves as collateral; 36–84-month terms
• Working capital line of credit — revolving for injectables inventory (Botox, Juvederm, Restylane, Sculptra), skincare products, payroll smoothing, and marketing spend; $25K–$500K range
• Practice acquisition loan — structured term loan or SBA 7(a) to buy an existing med spa including patient base, device fleet, and goodwill; SBA finances goodwill up to 70–90% LTV
• Revenue-based advance / MCA — advance on card receipts; high card volume at cash-pay med spas supports larger approvals; repaid as daily percentage of card sales

SBA program fit for medical spas

Medical spas organized as for-profit entities qualify for SBA programs under 13 CFR Part 121 size standards — NAICS 812199 operators qualify at average annual receipts under $9.0M, covering virtually all independent med spas. The SBA 7(a) program is the primary vehicle for build-outs and goodwill-inclusive acquisitions. Because physicians, NPs, and PAs may hold ownership stakes, the entity must be organized as permitted under state CPOM law for SBA eligibility to apply. The SBA 504 program applies to practices purchasing their own clinic space — a 10% borrower down payment with a fixed 20-year CDC rate. For startup med spas under 2 years, the SBA Microloan program through CDFI intermediaries offers up to $50K with business-planning support.

Common qualification thresholds for med spa loans

• SBA 7(a): 650+ owner FICO, 2+ years operating, 1.25x DSCR on normalized EBITDA, active medical director agreement on file, state CPOM-compliant entity structure, personal guarantee from all 20%+ owners
• Equipment financing: 600+ FICO, 1+ year in business; device serves as collateral; FDA 510(k) clearance status reviewed for device collateral valuation
• Working capital line of credit: 620+ FICO, 12+ months operating, $15K+ average monthly net deposits; injectables inventory turnover reviewed
• Practice acquisition (SBA 7(a)): buyer 650+ FICO; target practice DSCR 1.25x on trailing 12 months; 10–15% equity injection; medical director continuity documented
• SBA 504: 680+ FICO, 2+ years profitable, owner-occupied real estate, 10% down; CPOM-compliant entity required

Med-spa-specific underwriting concerns

Medical spa underwriters evaluate factors unique to the industry: (1) Medical director and CPOM compliance — most states prohibit unlicensed persons from owning or directing a medical practice; the medical director requirement varies by state from a supervising physician to a licensed NP or PA; the ownership structure must comply with state CPOM law or the SBA eligibility determination fails. (2) FDA device clearance — aesthetic devices used in med spas are regulated by the FDA under the Federal Food, Drug, and Cosmetic Act; FDA's 510(k) database lists clearance status for specific devices; a device operating outside cleared indications creates regulatory and liability exposure lenders flag as collateral risk. (3) Injectables cold-chain compliance — Botox and biologics require refrigerated storage and documented temperature logs; non-compliant storage makes the stock worthless and invalidates inventory collateral. (4) Device obsolescence — aesthetic technology cycles fast; lenders apply conservative residual value haircuts on devices older than 3–5 years. (5) Malpractice insurance continuity — a gap in medical malpractice coverage on the supervising physician or practice entity is flagged by all underwriters as operational and regulatory risk.